Selective Accumulation of Mature DC-Lamp+ Dendritic Cells in Tumor Sites Is Associated with Efficient T-Cell-Mediated Antitumor Response and Control of Metastatic Dissemination in Melanoma

Cancer Research

Volumn 64, Issue 6, 2004, Pages 2192-2198

  Movassagh, Mojgan ^a,e   Spatz, Alain ^a,e   Davoust, Jean ^a   Lebecque, Serge ^b   Romero, Pedro ^c   Pittet, Mikaël ^c   Rimoldi, Donata ^c   Liénard, Danièle ^c   Gugerli, Oliver ^c   Ferradini, Laurent ^d   Robert, Caroline ^a   Avril, Marie Françoise ^a   Zitvogel, Laurence ^a   Angevin, Eric ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b MERCK RESEARCH LABORATORIES   (United States)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d INSTITUT PASTEUR   (France)

^e GÉNÉTHON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CASE REPORT; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; LYMPHOCYTE; LYMPHOCYTE FUNCTION; MALE; MELANOMA; MEMORY CELL; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE; T LYMPHOCYTE; TUMOR IMMUNITY;

ADULT; ANTIGENS, CD; ANTIGENS, NEOPLASM; DENDRITIC CELLS; HUMANS; IMMUNOPHENOTYPING; LIGANDS; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHOCYTES, TUMOR-INFILTRATING; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MALE; MELANOMA; NEOPLASM PROTEINS; RECEPTORS, CHEMOKINE; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 12144289413     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-2969     Document Type: Article

References (30)

1. Boon T, Coulie PG, Van den Eynde EB. Tumor antigens recognized by T cells. Immunol Today 1997;18:267-8.
2. Rosenberg SA. A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity 1999;10:281-7.
3. Mackensen A, Carcelain G, Viel S, et al. Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J Clin Investig 1994;93:1397-402.
4. Coulie PG, Bruggen P. T-cell responses of vaccinated cancer patients. Curr Opin Immunol 2003;15:131-7.
5. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature (Lond.) 1998;392:245-52.
6. Nestle FO, Alijagic S, Gilliet M, et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 1998;4:328-32.
7. Schuler-Thurner B, Schultz ES, Berger TG, et al. Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide- loaded monocyte-derived dendritic cells. J Exp Med 2002; 195:1279-88.
8. Lana AM, Wen DR, Cochran AJ. The morphology, immunophenotype and distribution of paracortical dendritic leucocytes in lymph nodes regional to cutaneous melanoma. Melanoma Res 2001;11:401-10.
9. Bell D, Chomarat P, Broyles D, et al. In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med 1999;190:1417-26.
10. Banchereau J, Briere F, Caux C, et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
11. Geissmann F, Dieu-Nosjean MC, Dezutter C, et al. Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J Exp Med 2002;196:417-30.
12. Cochran AJ, Huang RR, Guo J, Wen DR. Current practice and future directions in pathology and laboratory evaluation of the sentinel node. Ann Surg Oncol 2001;8: 13S-7S.
13. Starz H, Balda BR, Kramer KU, Buchels H, Wang H. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma. Cancer 2001;91:2110-21.
14. Marchand M, van Baren N, Weynants P, et al. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int J Cancer 1999;80:219-30.
15. Motta I, Andre F, Lim A, et al. Cross-presentation by dendritic cells of tumor antigen expressed in apoptotic recombinant canarypox virus-infected dendritic cells. J Immunol 2001;167:1795-802.
16. Yee C, Savage PA, Lee PP, Davis MM, Greenberg PD. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. J Immunol 1999;162:2227-34.
17. Sallusto F, Mackay CR, Lanzavecchia A. The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol 2000;18:593-620.
18. Romero P, Valmori D, Pittet MJ, et al. Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma. Immunol Rev 2002;188:81-96.
19. Romero P, Dunbar PR, Valmori D, et al. Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes. J Exp Med 1998;188: 1641-50.
20. Drake DR III, Braciale TJ. Lipid raft integrity affects the efficiency of MHC class I tetramer binding and cell surface TCR arrangement on CD8+ T cells J Immunol 2001;166:7009-13.
21. Skinner PJ, Haase AT. In situ tetramer staining. J Immunol Methods 2002;268:29-34.
22. Schrama D, Pedersen LO, Keikavoussi P, et al. Aggregation of antigen-specific T cells at the inoculation site of mature dendritic cells. J Invest Dermatol 2002;119: 1443-8.
23. Saint-Vis B, Vincent J, Vandenabeele S. et al. A novel lysosome-associated membrane glycoprotein, DC-LAMP, induced upon DC maturation, is transiently expressed in MHC class II compartment. Immunity 1998;9:325-36.
24. Dieu MC, Vanbervliet B, Vicari A, et al. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med 1998;188:373-86.
25. Sozzani S, Luini W, Borsatti A, et al. Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines J Immunol 1997;159:1993-2000.
26. Randolph GJ. Is maturation required for Langerhans cell migration? J Exp Med 2002;196:413-6.
27. Homey B, Dieu-Nosjean MC, Wiesenborn A, et al. Up-regulation of macrophage inflammatory protein-3α/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol 2000;164:6621-32.
28. Page G, Lebecque S, Miossec P. Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: correlation with selective chemokine expression in rheumatoid synovium. J Immunol 2002;168:5333-41.
29. Kleeff J, Kusama T, Rossi DL, et al. Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer. Int J Cancer 1999;81:650-7.
30. Fleming MD, Pinkus JL, Alexander SW, et al. Coincident expression of the chemokine receptors CCR6 and CCR7 by pathologic Langerhans cells in Langerhans cell histiocytosis. Blood 2003;101:2473-5.